Gomes Thiago-Pallin, Palma Luiz-Felipe, Tornelli Maurício-José, Tornelli Helena-Regina, Fukuoka Cíntia-Yuki, Borsatti Maria-Aparecida
MSc. Graduate Dentistry Program, Ibirapuera University. São Paulo, SP, Brazil.
PhD. Graduate Dentistry Program, Ibirapuera University. São Paulo, SP, Brazil.
J Clin Exp Dent. 2022 Nov 1;14(11):e938-e943. doi: 10.4317/jced.59809. eCollection 2022 Nov.
Adjunctive hyaluronidase has been widely used for ophthalmic anesthesia; however, in Dentistry, very few studies are available so far. Thus, the present study aimed to evaluate anesthetic outcomes of adjunctive hyaluronidase administration following buccal infiltration of articaine with epinephrine for anesthesia of mandibular first molars.
Twenty-eight patients received a buccal supraperiosteal infiltration of 4% articaine with 1:100,000 epinephrine for anesthesia of the mandibular first molars, in a split-mouth approach. Afterward, randomly and using the same technique, they received either 1.0 mL of hyaluronidase (150 UTR/mL) or a placebo solution. Considering patients' pain perceptions provoked by electric and mechanical stimulations, as well as using a pain scale, success rate, action onset time, duration of both pulpal and soft tissue anesthesia, and pain immediately after both punctures and on the 2nd day were assessed.
The pulpal anesthetic success rate was 85.7% for hyaluronidase and placebo groups. Soft tissue anesthesia showed a shorter action onset time and a longer duration when hyaluronidase was used; however, there was no difference between the groups regarding action onset time and duration of pulpal anesthesia. Pain at the puncture sites did not differ between the groups, regardless of the time point evaluated.
Adjunctive hyaluronidase following buccal infiltration of articaine with epinephrine for mandibular first molars seems not to provide any advantage in anesthetic outcomes in which the nerve fibers are intraosseous (i.e., pulpal anesthesia). On the other hand, soft tissue anesthesia may be improved substantially by using this pharmacological strategy. Hyaluronidase, local anesthesia, dentistry.
辅助性透明质酸酶已广泛用于眼科麻醉;然而,在牙科领域,迄今为止相关研究非常少。因此,本研究旨在评估在下颌第一磨牙麻醉中,在含肾上腺素的阿替卡因颊部浸润麻醉后给予辅助性透明质酸酶的麻醉效果。
28例患者采用双侧口内法,接受4%含1:100,000肾上腺素的阿替卡因颊侧骨膜上浸润麻醉下颌第一磨牙。之后,随机且采用相同技术,他们分别接受1.0 mL透明质酸酶(150 UTR/mL)或安慰剂溶液。考虑到电刺激和机械刺激引起的患者疼痛感受,以及使用疼痛量表,评估成功率、起效时间、牙髓和软组织麻醉持续时间,以及穿刺后即刻和第2天的疼痛情况。
透明质酸酶组和安慰剂组的牙髓麻醉成功率均为85.7%。使用透明质酸酶时,软组织麻醉起效时间较短且持续时间较长;然而,两组在牙髓麻醉起效时间和持续时间方面无差异。无论评估的时间点如何,两组穿刺部位的疼痛无差异。
在下颌第一磨牙麻醉中,在含肾上腺素的阿替卡因颊部浸润麻醉后给予辅助性透明质酸酶,在神经纤维位于骨内的麻醉效果(即牙髓麻醉)方面似乎未提供任何优势。另一方面,使用这种药理学策略可显著改善软组织麻醉。透明质酸酶、局部麻醉、牙科。